
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comprehensive Metabolic Profiling and Genome-wide Analysis Reveal Therapeutic Modalities for Hepatocellular Carcinoma
Qi Feng, Jia Li, Zhuoran Qi, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 30
Qi Feng, Jia Li, Zhuoran Qi, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer
Wenwen Shao, Zhiheng Lin, Zhikai Xiahou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 29
Wenwen Shao, Zhiheng Lin, Zhikai Xiahou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 29
Unveiling the cellular landscape: insights from single-cell RNA sequencing in multiple myeloma
Xinhan Li, Zhiheng Lin, Fu Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
Xinhan Li, Zhiheng Lin, Fu Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy
Gaofeng Ni, Yuwei Sun, Hongling Jia, et al.
Translational Oncology (2025) Vol. 52, pp. 102280-102280
Closed Access | Times Cited: 3
Gaofeng Ni, Yuwei Sun, Hongling Jia, et al.
Translational Oncology (2025) Vol. 52, pp. 102280-102280
Closed Access | Times Cited: 3
CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression
JUNZHE YI, Binbin Li, Xiaomin Yin, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 6, pp. 1129-1139
Open Access | Times Cited: 11
JUNZHE YI, Binbin Li, Xiaomin Yin, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 6, pp. 1129-1139
Open Access | Times Cited: 11
Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways
Changwu Wu, Jun Tan, Hong Shen, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 8
Changwu Wu, Jun Tan, Hong Shen, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 8
CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress
Yuanjun Lu, Yau-Tuen Chan, Junyu Wu, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101015-101015
Open Access | Times Cited: 21
Yuanjun Lu, Yau-Tuen Chan, Junyu Wu, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101015-101015
Open Access | Times Cited: 21
Lipid Droplet-Targeting near-infrared carbon dots with High-Specificity Dual-Report function for diagnosing hepatocellular carcinoma and evaluating its pharmacodynamics
Junli Wang, Yuanqiang Sun, Jingyu Hu, et al.
Chemical Engineering Journal (2023) Vol. 474, pp. 145762-145762
Closed Access | Times Cited: 15
Junli Wang, Yuanqiang Sun, Jingyu Hu, et al.
Chemical Engineering Journal (2023) Vol. 474, pp. 145762-145762
Closed Access | Times Cited: 15
Programmable DNA‐Peptide Conjugated Hydrogel via Click Chemistry for Sequential Modulation of Peripheral Nerve Regeneration
Zhenyuan Wei, Xiaoxiao Li, Yi-Cheng Chen, et al.
Advanced Functional Materials (2025)
Closed Access
Zhenyuan Wei, Xiaoxiao Li, Yi-Cheng Chen, et al.
Advanced Functional Materials (2025)
Closed Access
Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung Adenocarcinoma
Shengyi Zhang, Xinhan Li, Zhikai Xiahou, et al.
Translational Oncology (2025) Vol. 54, pp. 102295-102295
Closed Access
Shengyi Zhang, Xinhan Li, Zhikai Xiahou, et al.
Translational Oncology (2025) Vol. 54, pp. 102295-102295
Closed Access
A Critical Review of the Prospect of Integrating Artificial Intelligence in Infectious Disease Diagnosis and Prognosis
Shuaibu Abdullahi Hudu, Ahmed Subeh Alshrari, Esra’a Jebreel Ibrahim Abu-Shoura, et al.
Interdisciplinary Perspectives on Infectious Diseases (2025) Vol. 2025, Iss. 1
Open Access
Shuaibu Abdullahi Hudu, Ahmed Subeh Alshrari, Esra’a Jebreel Ibrahim Abu-Shoura, et al.
Interdisciplinary Perspectives on Infectious Diseases (2025) Vol. 2025, Iss. 1
Open Access
ISG15 Enhances the Activity of γ‐Glutamate Cysteine Ligase to Suppress Apoptosis in High Fat Diet‐Promoted Hepatocellular Carcinoma
Xin-Ran Liu, Qian Ma, Jia Zhao, et al.
Advanced Science (2025)
Open Access
Xin-Ran Liu, Qian Ma, Jia Zhao, et al.
Advanced Science (2025)
Open Access
Endogenous protein S100A14 stabilizes glutaminase to render hepatocellular carcinoma resistant to sorafenib
Menghui Wang, Yueheng Li, Junhui Su, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Menghui Wang, Yueheng Li, Junhui Su, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
SKA3 targeted therapies in cancer precision surgery: bridging bench discoveries to clinical applications – review article
Dechao Feng, Jie Wang, Yuhan Xiao, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 4, pp. 2323-2337
Open Access | Times Cited: 4
Dechao Feng, Jie Wang, Yuhan Xiao, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 4, pp. 2323-2337
Open Access | Times Cited: 4
Single cell-spatial transcriptomics and bulk multi-omics analysis of heterogeneity and ecosystems in hepatocellular carcinoma
Jiazhou Ye, Yan Lin, Zhiling Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Jiazhou Ye, Yan Lin, Zhiling Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53
Quan Liao, Jianping Xiong
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 6
Open Access | Times Cited: 3
Quan Liao, Jianping Xiong
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 6
Open Access | Times Cited: 3
Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer
Wenxing Qin, Jia Li, Na Gao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Wenxing Qin, Jia Li, Na Gao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma
Ji‐Hua Ren, Xinyan Yao, Min-Li Yang, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 4, pp. 1274-1286
Open Access | Times Cited: 2
Ji‐Hua Ren, Xinyan Yao, Min-Li Yang, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 4, pp. 1274-1286
Open Access | Times Cited: 2
Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK –VEGF /MMPs signaling pathway
Li Tian, Y Huang, Yan Liu, et al.
IUBMB Life (2024)
Closed Access | Times Cited: 2
Li Tian, Y Huang, Yan Liu, et al.
IUBMB Life (2024)
Closed Access | Times Cited: 2
The KIT ligand KITLG promotes portal vein tumor thrombosis by up-regulating COL4A1 through STAT3-SMAD2 signaling in hepatocellular carcinoma
Feifei Mao, Yuqiang Cheng, Kang Wang, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 2
Feifei Mao, Yuqiang Cheng, Kang Wang, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 2
Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma
Dan Chen, Ayinuer Aierken, Hui Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Dan Chen, Ayinuer Aierken, Hui Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Clinical significance of RNA methylation in hepatocellular carcinoma
Qiongling Bao, Yifan Zeng, Qizhuo Lou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Qiongling Bao, Yifan Zeng, Qizhuo Lou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
光学显微成像助力肿瘤精准医疗
杨彬 Yang Bin, 岳蜀华 Yue Shuhua, 王璞 Wang Pu
Chinese Journal of Lasers (2024) Vol. 51, Iss. 9, pp. 0907004-0907004
Open Access | Times Cited: 1
杨彬 Yang Bin, 岳蜀华 Yue Shuhua, 王璞 Wang Pu
Chinese Journal of Lasers (2024) Vol. 51, Iss. 9, pp. 0907004-0907004
Open Access | Times Cited: 1
Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review
Zhouting Tuo, Ying Zhang, Dengxiong Li, et al.
Pharmacological Research (2024) Vol. 206, pp. 107302-107302
Open Access | Times Cited: 1
Zhouting Tuo, Ying Zhang, Dengxiong Li, et al.
Pharmacological Research (2024) Vol. 206, pp. 107302-107302
Open Access | Times Cited: 1
Mitochondria in tumor immune surveillance and tumor therapies targeting mitochondria
Lvyuan Li, Yi Zhang, Qiling Tang, et al.
Cellular Oncology (2024)
Closed Access | Times Cited: 1
Lvyuan Li, Yi Zhang, Qiling Tang, et al.
Cellular Oncology (2024)
Closed Access | Times Cited: 1
Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature
Vincent Tambay, Valérie–Ann Raymond, Corentine Goossens, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3232-3232
Open Access | Times Cited: 3
Vincent Tambay, Valérie–Ann Raymond, Corentine Goossens, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3232-3232
Open Access | Times Cited: 3